Testosterone, Testosterone Replacement Therapy, and Cardiovascular Disease: A Contemporary Review.
Whether low endogenous testosterone is causal for cardiovascular disease, and how the cardiovascular risk of testosterone replacement therapy should now be classified, remain contested, while US labeling has moved in 2 opposing directions within 16 months. We conducted a targeted narrative review reported in accordance...